Warning: The NCBI web site requires JavaScript to function. more...
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.
Related citations
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.
Cancer Res. 2006 May 15;66(10):5278-86.
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F.
Mol Oncol. 2010 Aug;4(4):357-68. Epub 2010 Jun 26.
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S.
Oncogene. 2003 Apr 3;22(13):2021-33.
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.
Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.
Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB.
Breast Cancer Res Treat. 1999 May;55(2):179-88.
Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, Done SJ.
Clin Cancer Res. 2008 Jul 15;14(14):4446-54.
Classification of ductal carcinoma in situ by gene expression profiling.
Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.
Breast Cancer Res. 2006;8(5):R61.
Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.
Aubele M, Cummings M, Walsch A, Zitzelsberger H, Nährig J, Höfler H, Werner M.
Anal Cell Pathol. 2000;20(1):17-24.
Analysis of gene expression in ductal carcinoma in situ of the breast.
Adeyinka A, Emberley E, Niu Y, Snell L, Murphy LC, Sowter H, Wykoff CC, Harris AL, Watson PH.
Clin Cancer Res. 2002 Dec;8(12):3788-95.
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH.
Breast Cancer Res. 2004;6(4):R308-15. Epub 2004 Apr 26.
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger AM.
Anticancer Res. 2003 May-Jun;23(3A):2043-51.
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.
Breast Cancer Res Treat. 2010 Sep;123(2):397-404. Epub 2009 Dec 1.
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.
Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM.
Breast Cancer Res. 2004;6(5):R499-513. Epub 2004 Jul 6. Erratum in: Breast Cancer Res. 2005;7(1):32.
Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.
Glöckner S, Lehmann U, Wilke N, Kleeberger W, Länger F, Kreipe H.
Lab Invest. 2001 Apr;81(4):565-71.
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J.
Breast Cancer Res. 2010;12(1):R3. Epub 2010 Jan 7.
Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.
Zikan M, Bohm J, Pavlista D, Cibula D.
Clin Transl Oncol. 2011 Sep;13(9):652-5.
Gene amplification in ductal carcinoma in situ of the breast.
Burkhardt L, Grob TJ, Hermann I, Burandt E, Choschzick M, Jänicke F, Müller V, Bokemeyer C, Simon R, Sauter G, Wilczak W, Lebeau A.
Breast Cancer Res Treat. 2010 Oct;123(3):757-65. Epub 2009 Dec 22.
Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Welzl G, Höfler H, Werner M.
Int J Cancer. 2000 Jan 1;85(1):82-6.
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
Park K, Han S, Kim HJ, Kim J, Shin E.
Histopathology. 2006 May;48(6):702-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on